Instead, providers will submit GLP-1 prescriptions and prior authorization requests to a central processer managed by CMS
Merck had other China deals in the last few months (LaNova Medicines and Curon Biopharmaceutical), but all deals are either early-stage (ongoing Phase 1) or pre-clinical (Hansoh)
This post sets out what each injection is, what the evidence says, what the risks are, and how we handle the decision at CoLaz
You should not take semaglutide if you are: Studies measuring the effectiveness of semaglutide for type 2 diabetes use HbA1c (a marker of long-term blood sugar level control)
Additionally, while animal studies provide valuable insights, translating those findings to humans can be difficult due to differences in physiology, organ aging, and species-specific drug metabolism